The goal of the study is to perform a retrospective study to evaluate biomarkers predictive of aggressive disease using Florescence In Situ Hybridization (FISH) among men with histologically confirmed, clinically localized disease (T1c- T2c) under Active Surveillance (AS).
Grant Development Work for Molecular Assay in Prostate Cancer
Investigator: Van Den Eeden, Stephen
Funder: Abbott Laboratories
